Skip Navigation LinksHome > February 2014 - Volume 9 - Issue 2 > Identification and Characterization of ALK Kinase Splicing I...
Journal of Thoracic Oncology:
doi: 10.1097/JTO.0000000000000050
Brief Reports

Identification and Characterization of ALK Kinase Splicing Isoforms in Non–Small-Cell Lung Cancer

de Figueiredo-Pontes, Lorena Lobo MD, PhD*; Wong, Daisy Wing-Sze MPhil; Tin, Vicky Pui-Chi MMedSci; Chung, Lap-Ping DPhil; Yasuda, Hiroyuki MD*; Yamaguchi, Norihiro MD, MPH*; Nakayama, Sohei MD*; Jänne, Pasi Antero MD, PhD; Wong, Maria Pik MD; Kobayashi, Susumu Soeda MD, PhD*; Costa, Daniel Botelho MD, PhD*

Collapse Box


Introduction: Anaplastic lymphoma kinase (ALK) rearrangements are present in an important subset of non–small-cell lung cancer (NSCLC) and predict for response to the tyrosine kinase inhibitor crizotinib. In this study, we evaluated the yet unknown frequency and functional role of ALK splicing isoforms in NSCLC.

Methods: We analyzed 270 cases of NSCLC for ALK kinase domain splicing aberrations and in addition generated constructs with full-length echinoderm microtubule-associated protein-like 4 (EML4)-ALK (E13;A20) and a splicing isoform.

Results: Splicing isoforms of the kinase domain of ALK—including complete skipping of exon 23 (ALKdel23, ALK p.I1171fs*42) and exon 27 (ALKdel27, ALK p.T1312fs*0)—were identified in 11.1% (30 of 270 cases) of NSCLC, and these changes coexisted with ALK rearrangements, KRAS mutations, and EGFR mutations. ALK splicing isoforms were observed with full-length EML4-ALK in crizotinib-naive and treated NSCLCs. ALK T1312fs*0 was unable to render cells solely dependent on ALK signaling. Unlike EML4-ALK and EML4-ALK p.L1196M, EML4-ALK T1312fs*0 did not autophosphorylate ALK or other phosphotyrosine sites. Coexpression of equal amounts of EML4-ALK T1312fs*0 and EML4-ALK did not result in resistance to crizotinib, whereas coexpression of EML4-ALK L1196M with EML4-ALK resulted in resistance to inhibition of ALK by crizotinib.

Conclusions: ALK kinase splicing isoforms were present in NSCLC and even if translated seemed to be nonfunctional variants of ALK.

Copyright © 2014 by the European Lung Cancer Conference and the International Association for the Study of Lung Cancer.


Article Tools


Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Other Ways to Connect



Visit on your smartphone. Scan this code (QR reader app required) with your phone and be taken directly to the site.

 For additional oncology content, visit LWW Oncology Journals on Facebook.